Cat.#: ACPP-1079
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg | inquiry |
| ACPP-1146 | Recombinant Human Artemin Protein (Fc Tag) (AC1146) | 50 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1277 | TSH beta Blocking Peptide (AC1277) | 250 µg | inquiry |
| ACPP-1715 | Mouse Acrp30 Protein, HEK (AC1715) | 2 µg | inquiry |
| ACPP-1655 | Human RAB23 Protein (AC1655) | 5 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1534 | Human RLN3 Protein (AC1534) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.